|
Volumn 24, Issue 11, 2004, Pages 1594-1633
|
High-impact articles related to the pharmacotherapeutic management of systolic heart failure
|
Author keywords
Chronic heart failure; Decompensated heart failure; Left ventricular systolic dysfunction; Systolic heart failure
|
Indexed keywords
ALDOSTERONE ANTAGONIST;
AMIODARONE;
ANGIOTENSIN;
ANGIOTENSIN RECEPTOR ANTAGONIST;
ANTICOAGULANT AGENT;
ANTITHROMBOCYTIC AGENT;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
CALCIUM CHANNEL BLOCKING AGENT;
CALCIUM SENSITIZER;
CAPTOPRIL;
CREATININE;
DIGOXIN;
DIURETIC AGENT;
DOFETILIDE;
ENALAPRIL;
ENDOTHELIN RECEPTOR ANTAGONIST;
ERYTHROPOIETIN;
GROWTH HORMONE;
HYDRALAZINE;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
IMMUNOMODULATING AGENT;
INOTROPIC AGENT;
ISOSORBIDE DINITRATE;
LISINOPRIL;
MATRIX METALLOPROTEINASE;
NESIRITIDE;
PHOSPHODIESTERASE INHIBITOR;
RENIN;
TUMOR NECROSIS FACTOR ALPHA;
UNINDEXED DRUG;
CLINICAL TRIAL;
CONGESTIVE HEART FAILURE;
COUGHING;
DEFIBRILLATOR;
DIZZINESS;
DRUG CHOICE;
DRUG EFFICACY;
DRUG INDICATION;
DRUG SAFETY;
HEADACHE;
HEART ASSIST DEVICE;
HUMAN;
HYPOTENSION;
KIDNEY FAILURE;
MEDICAL LITERATURE;
OUTCOMES RESEARCH;
PATHOPHYSIOLOGY;
PRACTICE GUIDELINE;
PROGNOSIS;
PUBLICATION;
REVIEW;
SYSTEMATIC REVIEW;
HEART FAILURE, CONGESTIVE;
HUMANS;
SYSTOLE;
|
EID: 7044236951
PISSN: 02770008
EISSN: None
Source Type: Journal
DOI: 10.1592/phco.24.16.1594.50942 Document Type: Review |
Times cited : (7)
|
References (0)
|